Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Scoping Review from 2009 to 2022

• Main Authors: Laura Torres-Canchala (Author), Daniela Cleves-Luna (Author), Oriana Arias-Valderrama (Author), Estephania Candelo (Author), María Angelica Guerra (Author), Harry Pachajoa (Author), Manuela Olaya (Author)
• Format: Book
• Published: MDPI AG, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Respiratory recurrent papillomatosis (RRP) is a fatal disease with no known cure. In severe RRP cases, systemic bevacizumab (SB) could be used as adjuvant therapy. Objective: This study aims to determine the extent and type of evidence in relation to the clinical outcomes of RRP after SB...